Hemostemix Inc.
HMTXF
$0.06
-$0.01-8.76%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 184.44% | -51.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 266.52% | -51.37% | |||
| Operating Income | -266.52% | 51.37% | |||
| Income Before Tax | -62.50% | 75.15% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -62.50% | 75.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -62.50% | 75.15% | |||
| EBIT | -266.52% | 51.37% | |||
| EBITDA | -266.52% | 51.37% | |||
| EPS Basic | -66.67% | 84.04% | |||
| Normalized Basic EPS | -411.11% | 84.75% | |||
| EPS Diluted | -66.67% | 84.04% | |||
| Normalized Diluted EPS | -411.11% | 84.75% | |||
| Average Basic Shares Outstanding | 0.00% | 54.09% | |||
| Average Diluted Shares Outstanding | 0.00% | 54.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||